This early-stage study is testing a new radioactive tracer called [89Zr]DFO-YS5 for PET scans in patients with multiple myeloma. The tracer is designed to attach to a specific protein (CD46) found on myeloma cancer cells, potentially helping doctors see the cancer more clearly. R…
Phase: PHASE1 • Sponsor: Robert Flavell, MD, PhD • Aim: Diagnosis
Last updated Mar 25, 2026 14:09 UTC